Untreated Negative Control Research Articles

Equine bone marrow-derived mesenchymal stromal cells reduce established S. aureus and E. coli biofilm matrix in vitro.

Biofilms reduce antibiotic efficacy and lead to complications and mortality in human and equine patients with orthopedic infections. Equine bone marrow-derived mesenchymal stromal cells (MSC) kill planktonic bacteria and prevent biofilm formation, but their ability to disrupt established orthopedic biofilms is unknown. Our objective was to evaluate the ability of MSC to reduce established S. aureus or E. coli biofilms in vitro. We hypothesized that MSC would reduce biofilm matrix and colony-forming units (CFU) compared to no treatment and that MSC combined with the antibiotic, amikacin sulfate, would reduce these components more than MSC or amikacin alone. MSC were isolated from 5 adult Thoroughbred horses in antibiotic-free medium. 24-hour S. aureus or E. coli biofilms were co-cultured in triplicate for 24 or 48 hours in a transwell plate system: untreated (negative) control, 30 μg/mL amikacin, 1 x 106 passage 3 MSC, and MSC with 30 μg/mL amikacin. Treated biofilms were photographed and biofilm area quantified digitally. Biomass was quantified via crystal violet staining, and CFU quantified following enzymatic digestion. Data were analyzed using mixed model ANOVA with Tukey post-hoc comparisons (p < 0.05). MSC significantly reduced S. aureus biofilms at both timepoints and E. coli biofilm area at 48 hours compared to untreated controls. MSC with amikacin significantly reduced S. aureus biofilms versus amikacin and E. coli biofilms versus MSC at 48 hours. MSC significantly reduced S. aureus biomass at both timepoints and reduced S. aureus CFU at 48 hours versus untreated controls. MSC with amikacin significantly reduced S. aureus biomass versus amikacin at 24 hours and S. aureus and E. coli CFU versus MSC at both timepoints. MSC primarily disrupted the biofilm matrix but performed differently on S. aureus versus E. coli. Evaluation of biofilm-MSC interactions, MSC dose, and treatment time are warranted prior to testing in vivo.

The therapeutic effect of 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol on chemically induced atopic dermatitis

Atopic dermatitis (AD) is the most common chronic inflammatory skin disease worldwide. However, it is still urgent to develop innovative treatments that can effectively manage refractory patients with unpredictable chronic disease courses. In this study, we evaluated the therapeutic efficacy of 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) as a novel agent for AD treatment using a human-like mouse model of AD. PLAG significantly improved 2,4-dinitrochlorobenzene (DNCB)-induced AD skin lesions compared to those in mice treated with DNCB alone. PLAG substantially modulated the AD-induced infiltration of monocytes and eosinophils into skin lesions and humoral systemic responses involving immunoglobulin E (IgE), interleukin (IL)-4, and IL-13, restoring them to a normal state. Next, we compared the therapeutic efficacy of PLAG and abrocitinib for severe AD treatment. PLAG exhibited a significant therapeutic effect on AD skin lesions compared to abrocitinib. Unlike abrocitinib, PLAG significantly reduced AD-induced eosinophil infiltration to a level similar to that observed in untreated negative controls. Notably, both PLAG and abrocitinib downregulated IgE, IL-4, and IL-13 in a similar pattern, reaching levels similar to those in the untreated negative controls. Our findings strongly suggest that PLAG may serve as a therapeutic agent for AD with an efficacy comparable to that of abrocitinib.

Acute Toxicity and IN VIVO Antischistosomal Effects of Entada africana Guill &amp; Perott (Fabaceae) Methanol Stem Bark Extract in Albino Mice

The study was aimed at determining the acute toxicity and schistosomicidal effects of methanol extract (ME) of Entada africana (E. africana), in albino mice. Fresh stem bark of E. africana was shade-dried and extracted by Soxhlet extraction. Acute toxicity was carried out on 6 groups of mice (n=3) of 6-week-old, sizes 27-30g; to determine the therapeutic index, piloerection signs and possible mortality (LD50) in 24h exposure period. Cercaria from B. globosus snails were shed under a 100W bulb for 2 hours. In vivo antischistosomal assays was by used of 6-weeks old (27-30g) mice. Set I (n=10) involved investigation on schistosomules infection in the mice, 3-7 days post infection (PI). Set II (n=10) was infected and treated with E. africana ME extract, at concentrations 10-100mg/l, 35th day, PI for 5 consecutive days. Set III (n=10), were infected and treated with praziquantel– PZQ (positive control). While set IV (n=10) were infected and untreated (negative control). All were sacrificed, 75th day of PI. Data were analyzed by GraphPad® prism 8.4, version 2020. Findings revealed that E. africana ME did not generate any harmful or clinical effect within 24h, post administration; and there were no obvious reactions such as paw licking, stooling, piloerection or immediate death, except at phase II, 5000mg/kg bwt, (1⁄3) being the highest dosage. Worm burden decreased with increase in concentrations, especially at 70-100mg/l. Lower concentrations (10mg/l), had high worm population (76.00±21.28). Infected and untreated group had highest worm population (189.67±32.52). E. africana ME stem bark extract, showed antischistosomal effect and worm reduction in a dose- dependent pattern.

Amino acid surface modified bioglass: A candidate biomaterial for bone tissue engineering1.

Bioglasses are solid materials consisted of sodium oxide, calcium oxide, silicon dioxide and phosphorus in various proportions and have used in bone tissue engineering. There have been ongoing efforts to improve the surface properties of bioglasses to increase biocompatibility and performance. The aim of the present study is to modify the bioglass surface with an amino acid mixture consisting of arginine, aspartic acid, phenylalanine, cysteine, histidine and lysine, to characterize the surface, and to evaluate the performance and biocompatibility in vitro and in vivo. The untreated bioglass, bioglass kept in simulated body fluid (SBF), and modified bioglass were used in further evaluation. After confirmation of the surface modification with FT-IR analyses and SEM analyses, MC3T3-E1 preosteoblasts adhesion on the surface was also revealed by SEM. The modified bioglass had significantly higher ALP activity in colorimetric measurement, rate of calcium accumulations in Alizarin red s staining, lower rate of cell death in Annexin-V/PI staining to determine apoptosis and necrosis. Having higher cell viability rate in MTT test and absence of genotoxicity in micronucleus test (OECD 487), the modified bioglass was further confirmed for biocompatibility in vitro. The results of the rat tibial defect model revealed that the all bioglass treatments had a significantly better bone healing score compared to the untreated negative control. However, the modified bioglass exhibited significantly better bone healing efforts especially during the first and the second months compared to the other bioglass treatment treatments. As a result, the amino acid surface modification of bioglasses improves the surface biocompatibility and osteogenic performance that makes the amino acid modified bioglass a better candidate for bone tissue engineering. RESEARCH HIGHLIGHTS: Bioglass surface modification with amino acids contributes to bioglass-tissue interaction with an improved cell attachment. Modified bioglass increases in vitro Alp activity and calcium accumulation, and also positively affects cell behavior by supporting cell adaptation. Bioglass exerts osteogenic potential in vivo especially during early bone healing.

Effects of Vitis vinifera Leaves on the Oxidative Status of New Zealand Rabbit Liver Infected with Eimeria stiedae

Background: Rabbits are the most important protein sources of animals for humans all over the world. Its production has increased significantly in recent years and it has become one of the most important animal sources in the Kingdom of Saudi Arabia. Coccidiosis is one of the most dangerous diseases affecting rabbits and other animals causing global economic losses. Plant extracts have been used as potential alternatives to chemotherapy because they do not have the negative consequences of tissue deposits and drug resistance. Methods: The current study examined the antioxidant activity of Vitis vinifera leaf extract (VVLE) in New Zealand rabbits infected with Eimeria stiedae. The extract was subjected to phytochemical analysis by FT-IR. A total of 35 male New Zealand rabbits were divided into seven groups. Group 1 served as the uninfected, untreated (negative control) group. Group 2 uninfected and treated at 400 mg/kg of extract to test for toxicity. Group 3 represented the infected, non-treated (positive control) group. While, groups 4, 5 and 6 comprised infected treated with at100 mg/kg, 200 mg/kg and 400 mg/kg of extracts, respectively. Finally, group 7 consisted of infected rabbits treated with Toltrazuril at a dosage of 5 mg/kg body weight. Result: The analysis of phytochemicals by FT-IR for Vitis vinifera leaf extract revealed the existence of 15 biologically active compounds. VVLE was able to decrease the induced weight loss due to infection. Moreover, the oxidative status due to E. stiedae infection had been changed after treatment with VVLE where the level of glutathione, malondialdehyde and nitric oxide was improved indicating the antioxidant activity of the VVLE. Our findings suggested that VVLE could boost the induced oxidative stress in the liver of infected New Zealand rabbits, but studies are needed to determine the mechanism of VVLE.

Halogenated Boroxine K2[B3O3F4OH] Modulates Metabolic Phenotype and Autophagy in Human Bladder Carcinoma 5637 Cell Line.

Halogenated boroxine K2[B3O3F4OH] (HB), an inorganic derivative of cyclic anhydride of boronic acid, is patented as a boron-containing compound with potential for the treatment of both benign and malignant skin changes. HB has effectively inhibited the growth of several carcinoma cell lines. Because of the growing interest in autophagy induction as a therapeutic approach in bladder carcinoma (BC), we aimed to assess the effects of HB on metabolic phenotype and autophagy levels in 5637 human bladder carcinoma cells (BC). Cytotoxicity was evaluated using the alamar blue assay, and the degree of autophagy was determined microscopically. Mitochondrial respiration and glycolysis were measured simultaneously. The relative expression of autophagy-related genes BECN1, P62, BCL-2, and DRAM1 was determined by real-time PCR. HB affected cell growth, while starvation significantly increased the level of autophagy in the positive control compared to the basal level of autophagy in the untreated negative control. In HB-treated cultures, the degree of autophagy was higher compared to the basal level, and metabolic phenotypes were altered; both glycolysis and oxidative phosphorylation (OXPHOS) were decreased by HB at 0.2 and 0.4 mg/mL. Gene expression was deregulated towards autophagy induction and expansion. In conclusion, HB disrupted the bioenergetic metabolism and reduced the intracellular survival potential of BC cells. Further molecular studies are needed to confirm these findings and investigate their applicative potential.

In vivo and in silico studies of the effects of oil extracted from Cannabis sativa L. seeds on healing of burned skin wounds in rats.

This study investigates the potential effects of cannabis seed oil (CSO) on the wound healing process. The aim was to assess the efficacy of CSO in treating skin wounds using an animal model and to explore its anti-inflammatory properties through in silico analysis. Eighteen male albino Wistar rats, weighing between 200 and 250g, were divided into three groups: an untreated negative control group, a group treated with the reference drug silver sulfadiazine (SSD) (0.01g/mL), and a group treated topically with CSO (0.962g/mL). The initial wound diameter for all groups was 1 cm. In silico studies were conducted using Maestro 11.5 to evaluate the anti-inflammatory effects of phytoconstituents against cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). CSO and SSD treatments led to a significant reduction (p <0.05) in the size of burned skin wounds by day 5, with contraction rates of 53.95% and 45.94%, respectively, compared to the untreated negative control group. By day 15, wounds treated with CSO and SSD had nearly healed, showing contraction rates of 98.8% and 98.15%, respectively. By day 20, the wounds treated with CSO had fully healed (100%), while those treated with SSD had almost completely healed, with a contraction rate of 98.97%. Histological examination revealed granulated tissue, neo-blood vessels, fibroblasts, and collagen fibers in wounds treated with CSO. In silico studies identified arachidic acid, γ-linolenic acid, and linolenic acid as potent inhibitors of COX-1 and COX-2. Serum biochemical parameters indicated no significant changes (p > 0.05) in liver and kidney function in rats treated with CSO, whereas a significant increase (p < 0.01) in ALAT level was observed in rats treated with SSD. The findings demonstrate that CSO has a promising effect on wound healing. The CSO treatment resulted in significant wound contraction and histological improvements, with no adverse effects on liver and kidney function.However, the study's limitations, including the small sample size and the need for detailed elucidation of CSO's mechanism of action, suggest that further research is necessary. Future studies should focus on exploring the molecular pathways and signaling processes involved in CSO's pharmacological effects.

Human plasma can modulate micronucleus frequency in TK6 and OE33 cells in vitro

In this paper, we studied the potential genotoxic effects of human plasma from healthy volunteers, as well as patients with gastro-oesophageal reflux disease, Barrett’s oesophagus (BO) and oesophageal adenocarcinoma (OAC) using the oesophageal adenocarcinoma cell line (OE33) and the lymphoblastoid cell line (TK6). Both TK6 and OE33 cells were treated with plasma (10 % volume, replacing foetal bovine serum (FBS) or horse serum (HS)) at different time points of 4 h (for the micronucleus (Mn) assay and the invasion assay) and 24 h (for the cell cycle studies). Plasma-induced effects on DNA damage levels, cell viability and the cell cycle were studied by the micronucleus assay, cytokinesis block proliferation index (CBPI) and flow cytometry respectively. The expression of IL-8 in supernatants of TK6 cells and IFN-β in OE33 cells was also analysed by enzyme-linked immunosorbent assay (ELISA). Finally, we carried out an assessment of cellular invasion of OE33 cells following plasma treatment.The results of the micronucleus assay confirmed the genotoxicity of direct plasma treatment from some participants through the increase in DNA damage in TK6 cells. Conversely, some individual patient plasma samples reduced background levels of TK6 cell Mn frequency, in an anti-genotoxic fashion. In TK6 cells, (on average) plasma samples from patients with Barrett’s oesophagus induced higher micronucleus levels than healthy volunteers (p= 0.0019). There was little difference in Mn induction when using plasma versus serum to treat the cells in vitro. Cell cycle results showed that direct plasma treatment had a marked impact on OE33 cells at 24 h (p=0.0182 for BO and p=0.0320 for OAC) by decreasing the proportion of cells in the S phase, while plasma exposure was less impactful on the cell cycle of TK6 cells. Invasion of OE33 cells was also seen to be non-significantly affected by plasma treatment of OE33 cells.The addition of N-acetyl cysteine NAC in a dose-dependent matter did not alter the formation of Mn in TK6 cells, suggesting that reactive oxygen species (ROS) are not the root cause of plasma’s genotoxicity. The concentration of IL-8 in TK6 cells and IFN-β in OE33 cells was significantly higher in cells treated with OAC-derived plasma than in the untreated negative control. Collectively, our results demonstrate that plasma-specific effects are detectable which helps us better understand some important aspects of the biology of blood-based biomarkers under development.

Effect of Live and Fragmented Saccharomyces cerevisiae in the Feed of Pigs Challenged with Mycoplasma hyopneumoniae.

Currently, the responsible use of antimicrobials in pigs has allowed the continuous development of alternatives to these antimicrobials. In this study, we describe the impact of treatments with two probiotics, one based on live Saccharomyces cerevisiae (S. cerevisiae) and another based on fragmented S. cerevisiae (beta-glucans), that were administered to piglets at birth and at prechallenge with Mycoplasma hyopneumoniae. Thirty-two pigs were divided into four groups of eight animals each. The animals had free access to water and food. The groups were as follows: Group A, untreated negative control; Group B, inoculated by nebulization with M. hyopneumoniae positive control; Group C, first treated with disintegrated S. cerevisiae (disintegrated Sc) and inoculated by nebulization with M. hyopneumoniae; and Group D, treated with live S. cerevisiae yeast (live Sc) and inoculated by nebulization with M. hyopneumoniae. In a previous study, we found that on Days 1 and 21 of blood sampling, nine proinflammatory cytokines were secreted, and an increase in their secretion occurred for only five of them: TNF-α, INF-α, INF-γ, IL-10, and IL-12 p40. The results of the clinical evolution, the degree of pneumonic lesions, and the productive parameters of treated Groups C and D suggest that S. cerevisiae has an immunomodulatory effect in chronic proliferative M. hyopneumoniae pneumonia characterized by delayed hypersensitivity, which depends on the alteration or modulation of the respiratory immune response. The data presented in this study showed that S. cerevisiae contributed to the innate resistance of infected pigs.

Immunomodulatory potential of Sarcophaga argyostoma larval hemolymph as a natural alternative to berenil in treating Trypanosoma evansi in vivo

This study compared effects of diminazene aceturate (berenil), commonly used to treat domestic animals infected with Trypanosoma evansi, with the hemolymph of Sarcophaga argyostoma larva. The hemolymph may be acting as a possible natural alternative to berenil, based on immunomodulation mediated inflammatory response. Inflammatory mediators and histopathological changes in liver, kidney, and spleen of albino mice experimentally infected with T. evansi were studied. Mice were divided into five groups: G1, uninfected, untreated (negative control); G2, T. evansi infected (positive control); G3, infected and treated with berenil; G4, infected and treated with hemolymph; G5, infected and treated with hemolymph 3 days before infection (prophylactic group). Animals in (G4) and (G5) exhibited a significant overall reduction in serum levels of IFN-γ. However, the reduction in TNF-α and IL-6 levels was more limited compared to (G2) and (G3). Notably, an elevation in IL-10 levels was observed compared to animals in other groups. Furthermore, the groups treated with hemolymph demonstrated an alleviation of T. evansi infection in contrast to the other groups. This study highlights that the administration of Sarcophaga argyostoma larval hemolymph at a dosage of 0.5 ml/kg significantly inhibited T. evansi organisms in vivo, showcasing a pronounced trypanocidal effect.

Immunomodulating Potential of Ekebergia capensis in Murine Schistosoma mansoni Juvenile and Adult Infection

Schistosomiasis is a neglected tropical disease occurring in sub-Saharan Africa and affecting almost 250 million people. The drug of choice for treatment for Schistosomiasis has been Praziquantel which has been used for many years and there is a need to develop new drugs. The immunomodulatory potential of Ekebergia capensis extract on both juvenile and adult Schistosoma mansoni infection in vivo was evaluated in this study. Swiss albino mice were infected individually with 90 S. mansoni cercariae and randomized into groups of five each for i) plant extract treated groups ii) positive control groups treated with conventional drugs PZQ or artemether iii) infected but untreated (negative control) groups. The mice were treated orally with aqueous extracts of E. capensis at doses of 200 and 400 mg/kg at 2 weeks (juvenile worms) and 7 weeks (adult worms) post-infection. Immune immune-enhancing potential of the medicinal plant was determined by analyzing the levels of cytokines in serum samples that were collected before and after treatment. A BD-Cytometric Bead Array (CBA) mouse Th1/Th2/Th17 kit was used to quantitate the levels of cytokines using a flow cytometer (FACS Calibur) and analysis of the data was done using FCAP software. Results indicated that the medicinal plant extract had an immunomodulatory effect. There was a significant increase (P&lt;0.05) in Th1 cytokines (IL-2, IFN- γ and TNF-α), a decrease in Th2 cytokines (IL-4, IL-6 and IL-10) and an increase in Th17 (IL-17). These findings confirm the potential use of medicinal plants in the management of schistosomiasis.

Effects of natural extract from medicinal herbs on broilers experimentally infected with Eimeria tenella

This study aimed to evaluate the effects of natural extracts from nine medicinal herbs (SMA) on the growth performance, immunity, and intestinal integrity of broilers experimentally infected with Eimeria tenella. A total of 252 one-day-old broiler chicks were divided into 7 groups with 3 replicates per group and 12 broilers per cage. The groups were uninfected–untreated blank control group (BC), infected–untreated negative control group (NC), SMA treatment groups, Chinese medicine positive control group (CM), and chemical drug positive control group (CD). The SMA groups were infected and fed a basal diet supplemented with 0.6 (SMA-L), 0.8 (SMA-M), and 1.0 (SMA-H) g/kg SMA. The CM and CD groups were infected and fed a basal diet supplemented with 15 g/kg Jiqiuchong San and 0.2 g/kg Diclazuril, respectively. Results showed that feeding SMA could significantly reduce the number of oocysts in infected chickens, especially 1.0 g/kg SMA, which exhibited moderate anticoccidial efficacy. When infected with E. tenella, the supplementation of 1.0 g/kg SMA increased the renal index; restored the hepatic, splenic, and bursal indexes to BC levels; increased the levels of immunoglobulin A (IgA), IgM, and IgY; and reduced the contents of tumor necrosis factor (TNF-α), interferon-γ (IFN-γ), interleukin-6 (IL-6), and IL-10 of the infected chickens. Moreover, treatment with 1.0 g/kg SMA alleviated the pathological changes in cecal tissue and increased the contents of zonula occludens-1 (ZO-1), occludin, claudin-1, and mucoprotein 2 (mucin-2) in cecal tissues of E. tenella-infected chickens. We found that 1.0 g/kg SMA reduced the number of oocysts, improved immunity, and alleviated intestinal barrier damage, which could improve the growth performance of infected chickens. Thus, SMA proved to be an effective natural extract against E. tenella and has the potential to be used as an efficient anticoccidial drug or additive.

In Vitro Effect of Low-level Laser Therapy on Candida albicans Colonies Isolated From Patients Undergoing Radiotherapy for Head and Neck Cancer.

Introduction: Studies on head and neck cancer (HNC) patients undergoing radiotherapy have revealed increased numbers of Candida spp., leading to oral candidiasis and oral mucositis. The effects of laser therapy on Candida spp. have been studied with varied results. This study aimed to investigate the effect of low-level laser therapy (LLLT) on C. albicans colonies isolated from HNC patients undergoing radiotherapy. Methods: This study included a treated group, wherein 11 C. albicans isolates were obtained from the saliva of HNC patients undergoing radiotherapy at a dose exceeding 30 Gy. The control groups consisted of an untreated negative control and a positive control treated with nystatin. The treatment groups were subjected to LLLT in continuous mode for 50 seconds at a wavelength of 976 nm, 0.1 W at a dose of 5 J/cm2 for Laser 1 (L1) group and 0.2 W at a dose of 10 J/cm2 for Laser 2 (L2) group. The tests were conducted using C. albicans inoculum equivalent to a 0.5-McFarland suspension on 96-well plates. All test group inoculums were then cultured on Sabouraud dextrose agar (SDA), and the colony count was assessed at 104 CFU/mL. Results: LLLT at 5 and 10 J/ cm2 reduced C. albicans colonies by 7.01% and 10.94%, respectively, but the reductions were not statistically significant (P>0.05). Nystatin eliminated all the colonies. Conclusion: LLLT shows potential for reducing C. albicans colonies in HNC patients undergoing radiotherapy. However, further studies with varied parameters and methods are necessary.

Vascular Endothelial Growth Factor Supplementation Enhance Skin Antioxidant Capacity in Hyperglycemic Rats

The fundamental reasons for delayed wound healing in diabetic animals include inadequate production of growth factors or their increased devastation. Vascular Growth Factor (VEGF) has a biological role in the healing process of mucosal and skin wounds, especially in the process of new vessel formation. We planned to examine the oxidant-antioxidant events that occur during healing with topical VEGF application in diabetic rats. Experiments were performed 36 adults female Wistar albino rat diabetes induced by streptozotocin. The incisional wounds were made on the dorsal region in the rats. Rats were separated to 3 groups: the untreated (negative control) group (n=12), the chitosan group (n=12), the chitosan + VEGF group (n=12). The treatments were continued for 3 and 7 days, excluding the control and negative control groups. Then, the animals were sacrificed on the 3rd and 7th days of wound healing. Antioxidant and oxidant parameters in skin tissue were measured using biochemical methods. Topical VEGF application was decreased the NOx levels on the 3rd day compared to other groups. Moreover, it increased wound tissue GSH and AA levels, subsequently contributing to the enhance tissue antioxidant capacity. In conclusion, VEGF application increases the antioxidant capacity of the tissue and simultaneously reduces the oxidative stress and thus gives a positive acceleration to the wound healing process.

Microemulsion based on methyl 3,4,5-trihydroxybenzoate for the topical treatment of cutaneous leishmaniasis: an in vivo assay

ABSTRACT Cutaneous leishmaniasis, caused by protozoa of the genus Leishmania, presents diverse clinical manifestations, and current therapeutic options have limitations, including long treatment periods, potential hospitalization, and excessive pain during treatment. Methyl gallate, a phenolic compound found in plants such as Libidibia ferrea, presents promising antileishmanial activity. Combining this compound with existing leishmaniasis medications could lead to reduced dosages and the minimization of side effects. This study aimed to assess the efficacy of a microemulsion containing methyl gallate, either on its own or in combination with Glucantime®, for the experimental treatment of cutaneous leishmaniasis in a 30-day in vivo assay using golden hamsters infected with Leishmania (Leishmania) amazonensis. The control groups included an untreated positive control and an uninfected, untreated negative control. After treatment, we evaluated clinical, parasitological, and biochemical parameters. While none of the treatments achieved clinical or parasitological cure, notable improvements were observed in the combined group, with significant reductions in snout skin lesions and parasite load when compared to the control. Biochemical parameters such as creatinine, CK-MB, GOT, and GPT remained unchanged, but urea and CPK levels significantly increased in all the experimental groups relative to the control. In conclusion, the integration of a topical methyl gallate microemulsion with intralesional Glucantime® showed potential as an effective treatment for cutaneous leishmaniasis. Further investigations into optimal dosages and therapeutic schemes are warranted in order to enhance treatment outcomes.

In vitro Assessment of Antibacterial Activity and Potential Genotoxic Effect of Fruit Extracts of Capparis spinosa L. Plant

This research was carried out to assess the minimum inhibitory concentration (MIC) and the genotoxic potential of ethanolic and aqueous (cold and hot) fruit extracts of Capparis spinosa L. (C. spinosa) plant against different types of bacterial strains. The antimicrobial effect of these extracts against the tested bacteria was investigated using broth microdilution method. The potential genotoxic effect was evaluated by ERIC-PCR technique. Results of the current study revealed that the MIC values of ethanolic fruit extract against the tested bacterial had a range of 12.5 mg/ml to 25 mg/ml. However, aqueous fruit extracts had an MIC with a range of 50 mg/ml to 100 mg/mL. The potential genotoxic activity of cold aqueous extract was determined according to the changes in ERIC-PCR profile of E. coli strain treated with extract in comparison to that untreated (negative control). Results of this study suggest the genotoxic effect of aqueous fruit extract on E. coli. Further research is required to assess and identify the biological molecules and their mechanisms in the context of the genotoxicity. In vivo genotoxicity assessment or with the presence of liver extract is recommended to evaluate the safety of using fruits for therapeutic purposes and a valuable nutrient source.

Bio-efficacy of Trichoderma harzianum Rifai and Botanical Extracts against Major Fungal Pathogens of Tamarind (Tamarindus indica L.) under Field Condition

Domestic production of tamarind has decreased in the country due to diseases. Tests were made on the individual efficacy of botanical extracts like plant growth promoter (PGP) and oriental herb nutrient (OHN), as well as the Trichoderma harzianum Rifai as a possible biocontrol agent against major fungal tamarind diseases. Using Randomized Complete Block Design (RCBD), a field setup was established with five treatments: untreated (negative control), synthetic fungicide, OHN, PGP, and T. harzianum having three replications per treatment. Results revealed that T. harzianum is an effective biocontrol agent against major fungal tamarind diseases. PGP having similar efficiency with T. harzianum significantly inhibited the infection and provided immediate defense from diseases. OHN is less effective due to delayed reduced infection. The research output is a significant help in the management of various diseases that is cost-effective and safe.

Mode of constant magnetic power effects on Escherichia coli viability and antibiotics activities

Background: The region that a magnetic force has an effect on is known as a magnetic field. Normally, two poles of this field are concentrated. Most magnetic objects are made up of a variety of tiny fields known as domains. There are many different techniques that have been published in the literature for using magnetic energy as a diagnostic tool and for treating illnesses in both humans and animals. Aims: To investigate the effects of different levels of static magnetic field on the ultra structure of Escherichia coli a bacterium as well as their antibiotics activities changes. Materials and Method: Locally created dipolar static magnetic field with strength 400, 800, 1200, and 1600 Gauss and used. Between July and October 2022, ten patients with urinary tract infections at Hawler Teaching Hospital and Raparren Hospital for Children in Erbil were isolated for E. coli and then identified by Vitek test. Bacterial culture medium in equal amounts of broth was subjected to the magnetic field for 24 hours. Additionally, treated E. coli culture media (Vitek test) was compared with untreated negative control samples in the bacterial growth subculture, which was checked for bacterial population using spectrophotometer and Vitek diagnosis kit depended on response to different types of antibiotics. Results: An recognized bacterial strain known as E. coli was subjected to magnetic field with two poles pressures of (400, 800, 1200, and 1600) Gausses while it was incubated for 24 hours at a temperature of 37oC. Optical density (O.D.) measurements at 620 nm were used. The results showed that the microorganisms' exposure to the magnetic field produced noticeable alterations on response to different types of antibiotics (Ceftazidime, Azetroname, Ceftazidime, Cefepime, Minocyclin, Azetroname, Ticarcillin/ Clavulanic acid, Azetroname, Piperacillin, Ceftazidime, Cefepime, Ciprofloxacin, Tobramycin, Imipenem, Meropenem, Amikacin, Nitrofurantin, Trimethoprim/ Sulfamethoxazole and Gentamycin) and significantly reduced the number of cells in the exposed bacteria as compared to the control. Conclusions: We came to the conclusion that due to bacterial mutation, the magnetic field could alter bacterial response to different types of antibiotics and bacterial population.

Combined effects of Ascophyllum nodosum seaweed extract and biological control agents on Meloidogyne javanica in soybean

This study aimed to investigate the efficacy of Ascophyllum nodosum extract, in combination or not with biocontrol agents, in the management of Meloidogyne javanica in soybean, assess treatment effects on soil biological activity, and determine the total phenolic content of the extract. The experiment was conducted according to a 5 × 2 factorial design, with three biocontrol agents (Bacillus methylotrophicus, Pochonia chlamydosporia, and Trichoderma harzianum), a chemical nematicide (abamectin, positive control), and an untreated (negative) control, each in the presence and absence of A. nodosum extract. Treatments included six replications. Nematode inoculation (2000 eggs + juveniles of M. javanica per plant) was performed at the time of sowing. Sixty days later, plants were evaluated for height, shoot weights, numbers of M. javanica eggs and J2 extracted from roots, and soil biological activity. Biological and chemical nematicide treatments were effective in reducing M. javanica multiplication. There was a synergic effect of A. nodosum extract on M. javanica multiplication for the treatments with A. nodosum + T. harzianum, A. nodosum + abamectin (Trial 1) and A. nodosum + P. chlamydosporia (Trial 2). B. methylotrophicus and T. harzianum treatments enhanced plant development and soil microbial biomass carbon. Higher values of soil basal respiration and metabolic quotient (qCO2) were observed in the A. nodosum + abamectin treatment. A. nodosum extracts at 75 g L−1 had a total phenolic content of 13 255 and 11 608 mg GAE 100−1 g in Trials 1 and 2, respectively.

Study on hemostatic activities of Aspilia africana (Pers.) C. D. Adams and Conyza canadensis L.

The process of hemostasis involves the body turning blood into a thick, gel-like mass at the site of injury or damage in order to stop bleeding. Africa and Latin America are the native habitats of Aspilia africana (Family Asteraceae). Hemorrhage plant and wild Sunflower are frequent names for this plant, which grows in savanna wastelands and forested areas. Conyza canadensis (Family Asteraceae) is commonly known as Canadian horseweed or Canadian fleabane. It is present in all warm nations, but because of its global distributions from America, it is thought to have originated there and spread to the rest of the world. This study investigated hemostatic activities of the leaves extract of Aspilia africana and Conyza canadensis on mice. Fresh leaves of the plant samples were extracted with methanol and thirty-two (32) mice grouped into eight of four mice were used for the study. Incision was made on the tail of each mouse. Warfarin, a standard drug (3 mg/kg), was used as positive control while each plant extract was made into concentrations of 50, 100 and 200 mg/kg. The bleeding time (seconds) of breaking tail and volume of bleeding were measured to evaluate the hemostatic activity after administration of treatments for 5 days (once per day). The results of this study showed reduction in the volume of bleeding in all the treatment groups when compared to untreated (negative control) group but highest activity was recorded in warfarin (Positive control). Aspilia africana (200 mg/kg) methanol extract (1.12±0.01) was not statistically different from the mean values of warfarin (1.11±0.01). The results of bleeding time (Seconds) in tails of the mice of warfarin, Aspilia africana methanol extract and Conyza canadensis methanol extract groups reduced when compared to the negative control group, but Aspilia africana extract gave highest activity at 200 mg/kg. The significant ability of Aspilia africana leaves extract to effectively arrest bleeding from fresh wounds and accelerate wound healing process might be attributed to the metabolites present. However, further studies should be carried out on its toxicity and mechanism of actions.